Cite

    Onur Bas et al.. “Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.” Journal of oncology pharmacy practice, vol. 26, 2020, pp. 1230–1233. http://access.bl.uk/ark:/81055/vdc_100104896069.0x000021